Similar articles

• Immunomodulating effects of T-44.

  Kunze A, Langner J, Machulla HK, Peter W, Bekemeier H. Kunze A, et al. Agents Actions. 1991 Jan;32(1-2):112-3. doi: 10.1007/BF01983332. Agents Actions. 1991. PMID: 2058456 No abstract available.
• Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis.

  Pasternak RD, Wadopian NS, Wright RN, Siminoff P, Gylys JA, Buyniski JP. Pasternak RD, et al. Agents Actions. 1987 Aug;21(3-4):241-3. doi: 10.1007/BF01966478. Agents Actions. 1987. PMID: 3500589
• Enhancement of graft-versus-host reaction and delayed cutaneous hypersensitivity in mice by ubenimex.

  Abe F, Hayashi M, Horinishi H, Matsuda A, Ishizuka M, Umezawa H. Abe F, et al. J Antibiot (Tokyo). 1986 Aug;39(8):1172-7. doi: 10.7164/antibiotics.39.1172. J Antibiot (Tokyo). 1986. PMID: 3093435
• Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.

  Bartlett RR, Dimitrijevic M, Mattar T, Zielinski T, Germann T, Rüde E, Thoenes GH, Küchle CC, Schorlemmer HU, Bremer E, et al. Bartlett RR, et al. Agents Actions. 1991 Jan;32(1-2):10-21. doi: 10.1007/BF01983301. Agents Actions. 1991. PMID: 2058454 Review.
• Effects of leflunomide on immune responses and models of inflammation.

  Bartlett RR, Anagnostopulos H, Zielinski T, Mattar T, Schleyerbach R. Bartlett RR, et al. Springer Semin Immunopathol. 1993;14(4):381-94. doi: 10.1007/BF00192310. Springer Semin Immunopathol. 1993. PMID: 8322168 Review. No abstract available.